ID | 61443 |
JaLCDOI | |
フルテキストURL | |
著者 |
Xu, Xiaolei
Division of Infectious Diseases, Chongqing Public Health Medical Center
Lu, Yanqiu
Division of Infectious Diseases, Chongqing Public Health Medical Center
Harypursat, Vijay
Division of Infectious Diseases, Chongqing Public Health Medical Center
Sun, Feng
Division of Infectious Diseases, Chongqing Public Health Medical Center
Zhao, Ting
Division of Infectious Diseases, Chongqing Public Health Medical Center
Zeng, Yanming
Division of Infectious Diseases, Chongqing Public Health Medical Center
He, Xiaoqing
Division of Infectious Diseases, Chongqing Public Health Medical Center
Chen, Yaokai
Division of Infectious Diseases, Chongqing Public Health Medical Center
|
抄録 | The optimal timing of antiretroviral therapy (ART) initiation in human immunodeficiency virus (HIV)-infected patients with cryptococcal meningitis (HIV/CM) is controversial. We designed a clinical trial to inves-tigate the optimal timing for ART initiation in HIV/CM patients. This will be a multicenter, prospective, and randomized clinical trial. Each enrolled patient will be randomized into either the early ART arm or the deferred ART arm. We will compare the mortality and incident rates of immune reconstitution inflammatory syndrome between the two arms. We hope to elucidate the optimal timing for ART initiation in HIV/CM patients.
|
キーワード | human immunodeficiency virus
meningitis
cryptococcal
antiretroviral therapy
|
Amo Type | Clinical Study Protocol
|
出版物タイトル |
Acta Medica Okayama
|
発行日 | 2021-02
|
巻 | 75巻
|
号 | 1号
|
出版者 | Okayama University Medical School
|
開始ページ | 109
|
終了ページ | 113
|
ISSN | 0386-300X
|
NCID | AA00508441
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
著作権者 | CopyrightⒸ 2021 by Okayama University Medical School
|
論文のバージョン | publisher
|
査読 |
有り
|
PubMed ID |